Login
Cart
Support
Search
Search
Search
DDW 2024 On Demand
Gwang Ha Kim
Appearances
View Grid
RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE ESOPHAGITIS [ZASTAPRAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]
Date
May 21, 2024
INTRODUCTION: Zastaprazan is a novel potassium-competitive acid blocker (P-CAB) with fast onset and prolonged duration. This study aims to assess the efficacy and safety of zastaprazan compared to esomeprazole in patient with erosive esophagitis…
Presenter
Jung-Hwan Oh
Speakers
Hyun-Soo Kim
Yonsei University Wonju College of Medicine
Dae Young Cheung
Hang Lak Lee
Dong Ho Lee
Gwang Ha Kim
Suck Chei Choi
Yu Kyung Cho
Woo Chul Chung
Ji Won Kim
Eunju Yu
Hyesoo Kwon
John Kim
Hwoon Yong Jung